NEUVIVO
Live / Allowed — Notice of allowance issued (as of 15 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99706778
- Mark type
- Stylized text
- Filed
- 17 Mar 2026
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Christopher M. Turk
Goods and services
- Class 005 — Pharmaceuticals: medicines and pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (als); medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medicines and pharmaceutical preparations for the treatment of central nervous system and peripheral nervous system diseases and disorders; medicines and pharmaceutical preparations for the treatment of viral diseases; medicines and pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines and pharmaceutical preparations for the treatment of innate immune system related diseases and disorders.
Owner
- Neuvivo, Inc., Palo Alto, CA, US
- Neuvivo, Inc., Palo Alto, CA, US
Prosecution history
- 15 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jun 2026 — ASSIGNED TO EXAMINER
- 17 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Mar 2026 — NEW APPLICATION ENTERED